临床经验
Copyright ©The Author(s) 2012.
世界华人消化杂志. 2012-09-28; 20(27): 2618-2621
在线出版 2012-09-28. doi: 10.11569/wcjd.v20.i27.2618
表2 PCCCL患者术后生存的单因素分析
变量DFS
OS
HR95%CIPHR95%CIP
性别0.3730.077-1.8190.2230. 310.36-2. 660.285
年龄(岁)0.8950.804-0.9960.0420.8870.785-1.0040.058
HBsAg06230.126-3.0800.5620.5810.068-4.9880.621
AFP(ng/mL)1.0041.001-1.0060.0141.0031.000-1.0060.027
ALT(U/L)1.0811.004-1.1640.0381.1371.033-1.2510.009
肝硬化0.2750.034-2.2520.2290.0320.000-89.5690.395
肿瘤直径(cm)3.0271.401-6.5390.0053.4541.370-8.7090.009
肿瘤数目3.0391.038-8.8920.0423.0391.038-8.8920.042
肿瘤分化0.3730.189-0.7370.0050.3560.16-0.7950.012
血管侵犯0.0000.000-0.1070.6780.0000.000-0.1070.678
PCCCL分型0.4610.122-1.7320.2510.3200.058-1.7630.190

引文著录: 苏英锋, 马宝庆, 魏鹏. 透明细胞型肝癌的临床病理特点及预后分析15例. 世界华人消化杂志 2012; 20(27): 2618-2621